Compound repurposing
Small molecule compounds are being studied for repurposing in COVID-19 treament and research. Multiple small molecules that are approved to treat other disorders have shown potential effects on key proteins involved in SARS-CoV-2 host cell entry and replication. Repurposing of existing compounds is advantageous for speed - reducing timescales compared to conventional drug discovery. Researchers can save up to 50% on these small molecules for COVID-19 research, as they are up to half the price of other suppliers.
Calyculin A (HB0161)
Description:Potent, selective protein phosphatase 1 / 2A inhibitor
Purity:>98%
Leupeptin hemisulfate (HB3958)
Description:Reversible trypsin-like and cysteine proteases inhibitor
Purity:>97%
- Description:
Phosphatase Inhibitor Cocktail solution for use in cell lysates and tissue extracts including samples containing detergents.
- Description:
Phosphatase Inhibitor Cocktail solution (with Calyculin A) for the inhibition of serine/threonine and alkaline phosphatases.
- Description:
Protease & Phosphatase Inhibitor Cocktail solution (EDTA free)
- Description:
Protease & Phosphatase Inhibitor Cocktail solution (plus EDTA)
- Description:
Protease Inhibitor Cocktail powder for general use to inhibit a broad range of proteases and esterases
- Description:
Protease Inhibitor Cocktail (EDTA free) solution for mammalian cell and tissue extract use